Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 09:07 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | AL | 34 beds | Grade C | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 013031 | SHELBY, AL | 34 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 34-bed community hospital in SHELBY, AL with $17.4M in net patient revenue and a 10.5% operating margin. The hospital serves a payer mix of 60.0% Medicare, 0.0% Medicaid, and 40.0% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.5% to 17.9% (+736bps).

Net Revenue HCRIS$17.4M
Current EBITDA COMPUTED$1.8M
Operating Margin COMPUTED10.5%
Occupancy HCRIS87.5%
Revenue / Bed COMPUTED$512K
Net-to-Gross HCRIS60.8%
Distress Probability MLnan%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
57
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of 10.5% places it above the state median. Among 57 size-comparable peers (17-68 beds), the median margin is -16.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (17-68), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)AL34$17.4M10.5%
ATHENS LIMESTONEAL66$88.9M-20.9%
RUSSELL MEDICAL CENTERAL45$75.3M-14.8%
JACK HUGHSTON MEMORIAL HOSPITAAL47$75.2M6.5%
EASTPOINTE HOSPITALAL66$56.6M-50.0%
NORTH BALDWIN INFIRMARYAL35$55.3M-3.3%
PRATTVILLE BAPTIST HOSPITALAL55$53.5M-16.2%
HIGHLANDS MEDICAL CENTERAL45$45.9M-30.2%
ST. VINCENTS ST. CLAIRAL40$40.8M8.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$365K+210bp18mo
Cost to Collect4.5%2.5%$348K+200bp12mo
Denial Rate Reduction12.0%6.5%$345K+198bp12mo
A/R Days Reduction5200.0%3800.0%$212K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$365K
Cost to Collect
$348K
Denial Rate Reduction
$345K
A/R Days Reduction
$212K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$1.8M
+ RCM Uplift+$1.3M
Pro Forma EBITDA$3.1M
Current Margin10.5%
Pro Forma Margin17.9%
WC Released (1x)$667K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.8M$24.9M8.83x54.6%
Base (11x exit)10.0x11.0x$2.8M$28.3M10.03x58.6%
Bull Case9.0x11.0x$2.5M$33.5M13.18x67.5%
Bull (12x exit)9.0x12.0x$2.5M$37.2M14.67x71.1%
Bear Case11.0x10.0x$3.1M$17.6M5.67x41.5%
Bear (11x exit)11.0x11.0x$3.1M$20.4M6.56x45.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 60.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 17-68 beds
  • Same-state prioritization (n=58)
  • Comp margins: P25=-29.4% / P50=-16.5% / P75=-3.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.